As of close of business last night, XORTX Therapeutics Inc.’s stock clocked out at $0.75, down -13.22% from its previous closing price of $0.87. In other words, the price has decreased by -$0.1150 from its previous closing price. On the day, 2805440 shares were traded. XRTX stock price reached its highest trading level at $0.8090 during the session, while it also had its lowest trading level at $0.7014.
To gain a deeper understanding of XRTX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.50 and its Current Ratio is at 6.50. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
As of this moment, XORTX’s Price-to-Earnings (P/E) ratio for their current fiscal year is 3.28.
Stock Price History:
Over the past 52 weeks, XRTX has reached a high of $2.48, while it has fallen to a 52-week low of $0.66. The 50-Day Moving Average of the stock is 0.8363, while the 200-Day Moving Average is calculated to be 1.2384.
It appears that XRTX traded 731.84K shares on average per day over the past three months and 4.69M shares per day over the past ten days. A total of 12.99M shares are outstanding, with a floating share count of 12.83M. Insiders hold about 3.74% of the company’s shares, while institutions hold 6.67% stake in the company. Shares short for XRTX as of Oct 13, 2022 were 204.37k with a Short Ratio of 0.15M, compared to 274.61k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 1.42% and a Short% of Float of 1.48%.
As of right now, 0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.